These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 37340091)

  • 1. Ketamine in neuropsychiatric disorders: an update.
    Johnston JN; Kadriu B; Kraus C; Henter ID; Zarate CA
    Neuropsychopharmacology; 2024 Jan; 49(1):23-40. PubMed ID: 37340091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective.
    Hashimoto K
    Psychiatry Clin Neurosci; 2019 Oct; 73(10):613-627. PubMed ID: 31215725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Ketamine in bipolar depression: focus on anhedonia.
    Gałuszko-Węgielnik M; Wiglusz MS; Słupski J; Szałach Ł; Włodarczk A; Górska N; Szarmach J; Jakuszkowiak-Wojten K; Wilkowska A; Cubała WJ
    Psychiatr Danub; 2019 Sep; 31(Suppl 3):554-560. PubMed ID: 31488790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
    Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
    J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rethinking ketamine and esketamine action: Are they antidepressants with mood-stabilizing properties?
    d'Andrea G; Pettorruso M; Lorenzo GD; Mancusi G; McIntyre RS; Martinotti G
    Eur Neuropsychopharmacol; 2023 May; 70():49-55. PubMed ID: 36867895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine.
    Hashimoto K
    Biochem Pharmacol; 2020 Jul; 177():113935. PubMed ID: 32224141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on ketamine and its two enantiomers as rapid-acting antidepressants.
    Zhang K; Hashimoto K
    Expert Rev Neurother; 2019 Jan; 19(1):83-92. PubMed ID: 30513009
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular Pharmacology and Neurobiology of Rapid-Acting Antidepressants.
    Gould TD; Zarate CA; Thompson SM
    Annu Rev Pharmacol Toxicol; 2019 Jan; 59():213-236. PubMed ID: 30296896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of ketamine and its metabolites as antidepressants.
    Hess EM; Riggs LM; Michaelides M; Gould TD
    Biochem Pharmacol; 2022 Mar; 197():114892. PubMed ID: 34968492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression.
    Zheng W; Zhou YL; Liu WJ; Wang CY; Zhan YN; Li HQ; Chen LJ; Li MD; Ning YP
    J Psychiatr Res; 2018 Nov; 106():61-68. PubMed ID: 30278319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacology of ketamine and esketamine as rapid-acting antidepressants].
    Pavlidi P; Megalokonomou A; Sofron A; Kokras N; Dalla C
    Psychiatriki; 2021 Dec; 32(Supplement I):55-63. PubMed ID: 34990380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant Efficacy and Tolerability of Ketamine and Esketamine: A Critical Review.
    Molero P; Ramos-Quiroga JA; Martin-Santos R; Calvo-Sánchez E; Gutiérrez-Rojas L; Meana JJ
    CNS Drugs; 2018 May; 32(5):411-420. PubMed ID: 29736744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status.
    Henter ID; Park LT; Zarate CA
    CNS Drugs; 2021 May; 35(5):527-543. PubMed ID: 33904154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence from preclinical and clinical metabolomics studies on the antidepressant effects of ketamine and esketamine.
    Cavaleri D; Riboldi I; Crocamo C; Paglia G; Carrà G; Bartoli F
    Neurosci Lett; 2024 May; 831():137791. PubMed ID: 38670523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (S)-norketamine and (2S,6S)-hydroxynorketamine exert potent antidepressant-like effects in a chronic corticosterone-induced mouse model of depression.
    Yokoyama R; Higuchi M; Tanabe W; Tsukada S; Naito M; Yamaguchi T; Chen L; Kasai A; Seiriki K; Nakazawa T; Nakagawa S; Hashimoto K; Hashimoto H; Ago Y
    Pharmacol Biochem Behav; 2020 Apr; 191():172876. PubMed ID: 32088360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials.
    Ballard ED; Wills K; Lally N; Richards EM; Luckenbaugh DA; Walls T; Ameli R; Niciu MJ; Brutsche NE; Park L; Zarate CA
    J Affect Disord; 2017 Aug; 218():195-200. PubMed ID: 28477497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (
    Zanos P; Highland JN; Stewart BW; Georgiou P; Jenne CE; Lovett J; Morris PJ; Thomas CJ; Moaddel R; Zarate CA; Gould TD
    Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6441-6450. PubMed ID: 30867285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The therapeutic role of ketamine and esketamine in treating psychopathological domains of depression.
    Jawad MY; Di Vincenzo JD; Badulescu S; Teopiz KM; Tabassum A; Ceban F; Mckenzie A; Meshkat S; Rosenblat JD; Ho RC; McIntyre RS
    Neuropharmacology; 2023 Feb; 223():109299. PubMed ID: 36336068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suicide Has Many Faces, So Does Ketamine: a Narrative Review on Ketamine's Antisuicidal Actions.
    Lengvenyte A; Olié E; Courtet P
    Curr Psychiatry Rep; 2019 Dec; 21(12):132. PubMed ID: 31797066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target deconvolution studies of (2R,6R)-hydroxynorketamine: an elusive search.
    Bonaventura J; Gomez JL; Carlton ML; Lam S; Sanchez-Soto M; Morris PJ; Moaddel R; Kang HJ; Zanos P; Gould TD; Thomas CJ; Sibley DR; Zarate CA; Michaelides M
    Mol Psychiatry; 2022 Oct; 27(10):4144-4156. PubMed ID: 35768639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.